Skip to main content
GemVax & KAEL Co.,Ltd. logo

GemVax & KAEL Co.,Ltd. — Investor Relations & Filings

Ticker · 082270 ISIN · KR7082270000 KO Manufacturing
Open in API
Filings indexed 651 across all filing types
Latest filing 2020-11-16 Legal Proceedings Report
Country KR South Korea
Listing KO 082270

About GemVax & KAEL Co.,Ltd.

https://gemvax.com/

GemVax & KAEL is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics. Its lead drug candidate is GV1001, a synthetic peptide composed of 16 amino acids, which has demonstrated multiple actions including the modulation of neuroinflammation and reduction of oxidative stress. The company's development pipeline primarily targets neurodegenerative diseases, such as Alzheimer's disease and Progressive Supranuclear Palsy (PSP). Other therapeutic areas under investigation include pancreatic cancer and benign prostatic hyperplasia. GemVax & KAEL is actively advancing its programs through clinical trials to evaluate the efficacy and safety of its novel treatments.

Recent filings

Filing Released Lang Actions
[기재정정]투자판단관련주요경영사항(알츠하이머병 치료제로서 GV 1001의 국내 제2상 임상시험 결과)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previous disclosure about clinical trial results for an Alzheimer's drug (GV1001). It details specific clinical trial outcomes, statistical analysis, and future plans. Since it is a formal regulatory announcement of material business information (clinical trial results) and does not fit into specific categories like 'Earnings Release' or 'Annual Report', it is classified as a general regulatory filing.
2020-11-16 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'GemVax & KAEL' (젬백스&카엘) covering the period from January 1, 2020, to September 30, 2020. It contains detailed financial information, corporate governance, shareholding structure, and management discussion, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-13 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, time, location (online), purpose, and target audience for the upcoming presentation. Since it is an announcement of an event rather than the presentation materials themselves, and it is under 5,000 characters, it falls under the category of a regulatory announcement regarding corporate activities.
2020-11-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when a party acquires a significant stake (typically 5% or more) in a company. It details the shareholding status, changes in ownership, and contractual relationships (such as pledges or loans) of the major shareholders. This falls under the category of 'Major Shareholding Notification' (MRQ).
2020-10-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and Korea Exchange. This type of filing is a standard regulatory disclosure in South Korea for insiders (directors, officers, and major shareholders) to report changes in their shareholdings. While it involves share transactions, it is specifically a regulatory disclosure of insider ownership status rather than a 'Director's Dealing' (which is often a summary of trades) or a 'Major Shareholding Notification' (which usually refers to the 5% rule). Given the specific regulatory nature of this filing in the Korean market, it falls under the 'Regulatory Filings' category as the most appropriate classification.
2020-10-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) where company insiders report changes in their shareholdings. This falls under the category of 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2020-10-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.